UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

(Amendment No. ___)*

 

AnPac Bio-Medical Science Co., Ltd.
(Name of Issuer)
 

Class A Ordinary Shares

Class B Ordinary Shares

(Title of Class of Securities)
 

Class A Ordinary Shares: 1,212,700

Class B Ordinary Shares: N/A

(G0393E 107)
 
December 31, 2020
(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

  ☐  Rule 13d-1(b)
   
  ☐  Rule 13d-1(c)
   
  ☒  Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

SCHEDULE 13G

 

CUSIP No. Class A: G0393E 107; Class B: N/A  

 

1 Names of Reporting Persons: He Yu
 
2 Check the appropriate box if a member of a Group (see instructions)
(a)  ☐
(b)  ☒
3 Sec Use Only
 
4 Citizenship or Place of Organization
USA

Number of
Shares
Beneficially
Owned by Each
Reporting Person
With:
5 Sole Voting Power
1,212,700 shares of Class A Ordinary Shares
6 Shared Voting Power
0
7 Sole Dispositive Power
1,212,700 shares of Class A Ordinary Shares
8 Shared Dispositive Power
0

9 Aggregate Amount Beneficially Owned by Each Reporting Person
1,212,700 shares of Class A Ordinary Shares
10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11 Percent of class represented by amount in row (9)
10.06% of Class A Ordinary Shares (1)
12 Type of Reporting Person (See Instructions)
IN

  

(1)The calculations in the table below are based on 12,055,760 ordinary shares (including 9,192,660 Class A ordinary shares and 2,863,100 Class B ordinary shares) outstanding as of February 8, 2021.

 

Page 2 of 6

 

 

Item 1.

 

(a) Name of Issuer: AnPac Bio-Medical Science Co., Ltd.

 

(b) Address of Issuer’s Principal Executive Offices: 801 Bixing Street, Bihu County Lishui, Zhejiang Province 323006, People’s Republic of China

 

Item 2.

 

(b) Address of Principal Business Office or, if None, Residence:

Commence Chambers, P.O. Box 2208, Road Town, Tortola, British Virgin Islands.

 

(c)

Citizenship:

(1)    He Yu: USA

 

(d)

Title and Class of Securities:

Class A Ordinary Shares, par value $0.01 per ordinary share

Class B Ordinary Shares, par value $0.01 per ordinary share

 

(e)

CUSIP No.:

Class A Ordinary Shares: G0393E107

Class B Ordinary Shares: N/A

 

Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

  (a) Broker or dealer registered under Section 15 of the Act;
       
  (b) Bank as defined in Section 3(a)(6) of the Act;
       
  (c) Insurance company as defined in Section 3(a)(19) of the Act;
       
  (d) Investment company registered under Section 8 of the Investment Company Act of 1940;
       
  (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
       
  (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
       
  (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
       
  (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
       
  (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
       
  (j) A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
       
  (k) Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____________

 

Page 3 of 6

 

 

Item 4. Ownership

  

The percentages of ownership set forth below are based on 12,055,760 ordinary shares (including 9,192,660 Class A ordinary shares and 2,863,100 Class B ordinary shares) outstanding as of February 10, 2021.

 

   Name   Class A (1)   Class B (1) 
(a)    Amount Beneficially Owned  He Yu   1,212,700    0%
(b)    Percentage of class  He Yu   10.06%   0%
(c)     Number of shares as to which the person has:             
(i)       Sole power to vote or to direct the vote:  He Yu   1,212,700    0 
(ii)      Shared power to vote or to direct the vote:  He Yu   0    0 
(iii)     Sole power to dispose or to direct the disposition of:  He Yu   1,212,700    0 
(iv)     Shared power to dispose or to direct the disposition of:  He Yu   0    0 

 

Page 4 of 6

 

 

Item 5. Ownership of Five Percent or Less of a Class.

 

Not Applicable.

 

Item 6. Ownership of more than Five Percent on Behalf of Another Person.

 

Not Applicable.

 

Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

 

Not Applicable.

 

Item 8. Identification and classification of members of the group.

 

Not Applicable.

 

Item 9. Notice of Dissolution of Group.

 

Not Applicable.

 

Item 10. Certifications.

 

By signing below the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Page 5 of 6

 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 11, 2021

 

He Yu  
   
/s/ He Yu  
He Yu  

 

 

Page 6 of 6